This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Langaee, T. Y.
Right arrow Articles by Huletsky, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Langaee, T. Y.
Right arrow Articles by Huletsky, A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 1998, p. 3296-3300, Vol. 42, No. 12
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

An ampD Gene in Pseudomonas aeruginosa Encodes a Negative Regulator of AmpC beta -Lactamase Expression

Taimour Yousef Langaee, Michèle Dargis, and Ann Huletsky*

Département de biologie médicale, Pavillon Marchand, Université Laval, Ste-Foy, Québec, Canada G1K 7P4

Received 6 April 1998/Returned for modification 28 July 1998/Accepted 23 September 1998

    ABSTRACT
Top
Abstract
Text
References

The ampD and ampE genes of Pseudomonas aeruginosa PAO1 were cloned and characterized. These genes are transcribed in the same orientation and form an operon. The deduced polypeptide of P. aeruginosa ampD exhibited more than 60% similarity to the AmpD proteins of enterobacteria and Haemophilus influenzae. The ampD product transcomplemented Escherichia coli ampD mutants to wild-type beta -lactamase expression.

    TEXT
Top
Abstract
Text
References

Most Pseudomonas aeruginosa strains, like nearly all members of the family Enterobacteriaceae, express an inducible chromosomally encoded AmpC beta -lactamase (cephalosporinase) (27), which is placed in class C of Ambler's classification (1) and which is in Bush's group 1 (3). In enterobacteria, the regulation of AmpC beta -lactamase expression is intimately linked to cell wall recycling and involves three genes; ampR, which encodes a transcriptional regulator of the LysR family; ampG, which encodes a transmembrane permease; and ampD, which encodes a cytosolic N-acetyl-anhydromuramyl-L-alanine amidase hydrolyzing 1,6-anhydromuropeptides (9, 12, 15, 25). In the absence of a beta -lactam inducer, AmpR is repressed by the murein precursor UDP-MurNAc-pentapeptide (uridine- pyrophosphoryl-N-acetylmuramyl-L-alanyl-D-glutamyl-meso-diaminopimelic acid-D-alanyl-D-alanine) (13). Since beta -lactams interfere with murein synthesis, their actions lead to an increased periplasmic accumulation of degradation products such as 1,6-anhydromuropeptides, which are the signal molecules for beta -lactamase induction (5, 11). ampG transports these products from periplasm to cytoplasm, where they are cleaved by AmpD, which acts as a negative regulator of AmpC beta -lactamase expression (5, 11, 15, 25). In ampD mutants, the constitutive overproduction of AmpC beta -lactamase is accompanied by an ac- cumulation of aM-tripeptide (monosaccharide-tripeptide, 1,6-anhydro-N-acetylmuramyl-L-alanyl-D-glutamyl-meso-di-aminopimelic acid) and aM-pentapeptide (monosaccharide-pentapeptide, 1,6-anhydro-N-acetylmuramyl-L-alanyl-D-glu-tamyl-meso-diaminopimelic acid-D-alanyl-D-alanine) in the cytoplasm (5, 11). Jacobs et al. (13) suggested that the aM-tripeptide could be the AmpR-activating ligand, since this product can relieve in vitro the repressed state of AmpR, resulting in the activation of beta -lactamase expression. However, potential interactions of the aM-pentapeptide with AmpR have not been investigated. Another gene, ampE, which encodes a transmembrane protein, forms an operon with ampD, but this gene is not involved in beta -lactamase expression (10, 19, 24).

In P. aeruginosa, the inducible expression of AmpC beta -lactamase is also under the control of the transcriptional regulator AmpR (21). To further elucidate the induction process, the ampD and ampE genes of this organism were cloned and characterized, and complementation analysis was performed with Escherichia coli ampD mutants with the cloned P. aeruginosa ampD and ampE genes. A part of this work was presented before (16).

The strains and plasmids used in this study are described in Table 1. E. coli DH5alpha was used as the host for construction and propagation of recombinant plasmids. Bacterial cells were grown in tryptic soy broth or tryptic soy agar (Difco Laboratories, Detroit, Mich.). When required, 50 µg of kanamycin/ml, 30 µg of chloramphenicol/ml, and various concentrations of cefotaxime, ampicillin, and cefoxitin were added (Sigma-Aldrich Canada, Oakville, Ontario, Canada).

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1.   Characteristics of the bacterial strains and plasmids used in this study

Recombinant DNA techniques were performed essentially by standard procedures (26). To clone the ampD and ampE genes of P. aeruginosa PAO1, two degenerated oligonucleotide primers adapted to the P. aeruginosa codon usage and derived from two conserved regions of the E. coli, Citrobacter freundii, and Enterobacter cloacae AmpD amino acid sequences (10, 14, 19) were synthesized on a 394 DNA/RNA synthesizer (PE Applied Biosystems, Foster City, Calif.). The sequences of the primers were as follows: AmpD1, 5'-CGCTGCCSCCSGGCGARTTCG-3'; and AmpD2, 5'-CGGGGCCSGGGTCGGTCTTGC-3'. A 400-bp DNA fragment was amplified by PCR with the Taq DNA polymerase (Promega, Madison, Wis.) and a P. aeruginosa PAO1 lysate, the latter of which was prepared by the freezing-and-boiling method (30). This DNA fragment was used as a probe to screen a lambda  Zap Express genomic library of P. aeruginosa PAO1. Phage screening and in vivo plasmid excision were performed according to the instructions of the manufacturer (Stratagene, La Jolla, Calif.). A single phage containing a 6.7-kb genomic insert was selected, and plasmid pBK-CMV was excised out of the phage and named pHUL4DE-PH. The ampD gene was located on a 2.6-kb EcoRI fragment of pHULDE-PH, which was cloned into the EcoRI site of pBGS19+ vector to generate plasmid pHUL4DE-1. Both strands of this DNA fragment were sequenced with the Deaza sequencing kit (Pharmacia Biotech, Baie d'Urfé, Québec, Canada) on a Pharmacia LKB Macrophor or the ABI Prism dye terminator cycle sequencing kit with AmpliTaq DNA polymerase, FS (PE Applied Biosystems), on a 373 DNA sequencer (PE Applied Biosystems). Sequence analysis, alignment, the homology study, G + C content calculation, and molecular mass prediction were done with the Genetics Computer Group software package version 9.0 (Madison, Wis.). The PSORT software was used to predict protein localization sites (22).

Sequence analysis of this DNA fragment revealed three complete open reading frames (ORFs) (Fig. 1). The first 567-bp ORF is located 657 nucleotides downstream of the EcoRI site and encodes a 188-amino-acid polypeptide (AmpD) with a predicted molecular mass of 21 kDa. A potential Shine-Dalgarno (SD) sequence (AGGAG) (8) and the consensus -10 (TAGAGT) and -35 (TCGTCA) regions of bacterial promoters (20) were identified 5, 23, and 45 nucleotides upstream of the ampD ATG start codon, respectively. Following ampD, a second ORF (AmpE) of 837 nucleotides, which consists of 278 amino acids with a predicted molecular mass of 31 kDa, was found. The ampE ATG start codon overlaps the ampD TGA termination codon and is preceded by a potential SD sequence (AGGAG) located 5 nucleotides upstream. This strongly suggests that these two genes form an operon, as described for E. coli (10, 19). The G + C contents of ampD and ampE were calculated to be 64 and 68%, respectively, which are typical for P. aeruginosa (32). Finally, 92 nucleotides downstream of the ampE TGA stop codon, a 282-bp ORF (ORF-1), which comprises 93 amino acids with a predicted molecular mass of 10 kDa (Fig. 1), was identified. This ORF is transcribed in the same orientation as ampDE and is preceded by a potential SD sequence (AGGTG) as well as the -10 (CGATAT) and -35 (TTAACC) promoter-like sequences at 11, 25, and 52 nucleotides upstream of its ATG start codon, respectively. The product of ORF-1, like AmpD, possesses the features of a cytoplasmic protein (22). Three other potential ORFs (ORF-a, ORF-b, and ORF-c) from different reading frames, which are incomplete at the 5' end, were also identified on each side of ampDE (Fig. 1). However, these ORFs, like ORF-1, showed no significant homology to any sequence in the GenBank database.


View larger version (72K):
[in this window]
[in a new window]
 
FIG. 1.   Nucleotide sequence of the P. aeruginosa ampD and ampE genes with ORF-1 and predicted amino acids. The amino acids are presented according to the one-letter code. The putative SD sequences and the potential -10 and -35 regions of promoters are underlined. The stop codons are shown by asterisks. The five transmembrane domains of AmpE are boxed and named I, II, III, IV, and V. The stop codons for the potential ORF-a, ORF-b, and ORF-c are boxed. The oligonucleotide primers used for PCR amplification are shown by dashed arrows.

The predicted P. aeruginosa AmpD protein exhibited 65, 63, 62, and 62% similarity to the E. coli, C. freundii, E. cloacae, and putative Haemophilus influenzae AmpD proteins, respectively (7, 10, 14, 19). Amino acid sequence alignment of these AmpD proteins revealed many conserved motifs (Fig. 2). The conserved core region as well as the four strictly identical residues outside of this region, which relate the AmpD proteins of enterobacteria to the cell wall hydrolases of Bacillus spp. (12), were found in the P. aeruginosa AmpD protein. The deduced P. aeruginosa AmpE protein possesses the features of a cytoplasmic membrane protein (22) with five transmembrane-spanning domains (Fig. 1). It showed a low degree of similarity (33%) to its homolog in E. coli (10, 19) and seems to be less conserved than AmpD. Indeed, this difference with regard to AmpE is underlined by the fact that despite the identification of a putative ampD sequence in the genome sequence database of H. influenzae, no ampE sequence could be identified (7).


View larger version (43K):
[in this window]
[in a new window]
 
FIG. 2.   Alignment of the amino acid sequence of P. aeruginosa PAO1 AmpD with those of the E. coli, C. freundii, E. cloacae, and putative H. influenzae AmpD proteins. The similar and identical amino acids are lightly and darkly shaded, respectively. The crosses and the open squares indicate the amino acids conserved in the core and outside region of the Bacillus cell wall hydrolases, respectively. The solid squares show the amino acids strictly conserved in various cell wall hydrolases (12).

To determine the role of the P. aeruginosa ampD and ampE gene products, complementation analyses were performed with E. coli strains JRG582 [Delta (ampDE)2] and STC172 (ampD11E+) (10, 18) with the cloned P. aeruginosa ampD and ampE genes. The MICs of beta -lactam antibiotics for transformants were determined by the broth microdilution method as described previously (31). Induction assays and beta -lactamase activity measurements were performed as described previously (31). Two plasmids were constructed to do a complementation study. Plasmid pHUL4DE-2, which contains the ampDE operon and the 105- and 209-nucleotide regions located upstream and downstream of this operon, respectively, was constructed as follows: a 1,714-bp DNA fragment was amplified by PCR with the Pfu DNA polymerase (Stratagene) and the oligonucleotide primers AmpD-14 (5'-GGGAATTCCTTTCCTCGAAGCATGTCG-3') and AmpD-15 (5'-GGGATAGAGTACGGTCTTC-3') (Fig. 1). This DNA fragment was cloned into the SmaI site of pBGS19+ vector. Plasmid pHUL4D, which contains the complete ampD gene and the first 317 nucleotides encoding AmpE, was constructed by cloning a 984-bp DNA amplification product into the SmaI site of pBGS19+ vector. This fragment was amplified as described above with the oligonucleotide primers AmpD-14 and AmpE-4 (5'-CGCCGCCAGGCGTCGCG-3') (Fig. 1). The sequences of all cloned PCR DNA fragments were confirmed by complete resequencing.

Since E. coli strains do not contain ampR (24), the E. coli strains STC172 and JRG582 were first transformed with plasmid pEC1C carrying ampC and ampR of E. cloacae (23). The data in Table 2 show that STC172/pEC1C exhibits a high basal beta -lactamase activity and is hyperinducible, while JRG582/pEC1C has a fully derepressed phenotype, as shown previously (10). Both of these constructs were highly resistant to ampicillin and cefotaxime. The ampD genes of both E. coli and P. aeruginosa, as expressed from pNH5 and pHUL4D, respectively, transcomplemented the E. coli ampD and ampDE mutants to low-level beta -lactam resistance and wild-type beta -lactamase expression (low basal level and inducibility) (Table 2). This shows that the cloned P. aeruginosa ampD gene expresses a functional AmpD protein in E. coli cells. These data, as well as the high homology observed among the AmpD proteins, strongly suggest that P. aeruginosa AmpD acts as an N-acetyl-anhydromuramyl-L-alanine amidase, which leads to a decreased amount of anhydromuropeptide, the signal molecule for beta -lactamase expression (5, 9, 11, 12). The induced/noninduced ratio of beta -lactamase activity was more than 7.5 times lower in cells producing the E. coli AmpD than that in cells containing P. aeruginosa AmpD, and this could be explained by the presence of a very strong promoter behind E. coli ampD.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 2.   MICs of beta -lactam antibiotics and specific activities of E. cloacae AmpC in E. coli STC172 and JRG582 containing the E. coli ampD and P. aeruginosa ampD and ampE genes

The MICs, as well as the basal and induced levels, of beta -lactamase were almost the same for cells containing AmpD as those for cells containing AmpD and AmpE. This strongly suggests that similar to the E. coli protein, P. aeruginosa AmpE has no effect on beta -lactamase expression (24). This protein, like its homolog in E. coli (10, 19), has the features of an integral inner membrane protein, but its role in the bacterial cell is still unknown.

Expression of ORF-1 together with ampDE from plasmid pHULDE-1 reduced by more than 1.7-fold the induced level of beta -lactamase in both E. coli ampD and ampDE mutants, compared to that in strains producing AmpD and AmpE. This suggests that the product of this ORF, which has the features of a cytoplasmic protein, may affect beta -lactamase expression in the presence of a beta -lactam inducer, perhaps by interacting directly with AmpD or by acting as a regulator of ampD expression, or perhaps by a new unknown mechanism. Further experiments are needed to explore the role of this ORF.

The high degree of homology among the various AmpD proteins shows that AmpD of P. aeruginosa is in its evolution very close to its homologs in enterobacteria, and they probably share a common mechanism of regulation of AmpC beta -lactamase expression and murein metabolism. In our approach to characterizing the mechanism of regulation of AmpC beta -lactamase production in P. aeruginosa, a putative ampG gene was also cloned and characterized (17). This further strengthens the close relationships between the P. aeruginosa and enterobacterial AmpC beta -lactamase induction mechanism and cell wall recycling.

In enterobacteria, three out of four phenotypes of altered beta -lactamase expression have been associated with mutations in ampD (2, 6, 10, 14, 19, 29). In clinical and laboratory isolates of P. aeruginosa, three phenotypes of altered beta -lactamase expression have also been described (4, 27), and a study is in progress to characterize the ampD gene in some of these isolates.

Nucleotide sequence accession number. The nucleotide sequence data for the ampD and ampE genes appear in the GenBank database under accession no. AF082575.

    ACKNOWLEDGMENTS

We thank S. T. Cole, Institut Pasteur, Paris, France, for E. coli JRG582 and STC172 and plasmids pEC1C and pNH5; G. Vézina, Université Laval, for the lambda  ZAP Express genomic library of P. aeruginosa PAO1; L. Gagnon, Université Laval, for assistance with computer analysis; and M. Goldner, Université Laval, for critically reading the manuscript.

This work was supported by the Canadian Cystic Fibrosis Foundation and, in part, by Canada's Networks of Centres of Excellence (CBDN).

    FOOTNOTES

* Corresponding author. Mailing address: Département de biologie médicale, Pavillon Marchand, Université Laval, Ste-Foy, Québec Canada G1K 7P4. Phone: (418) 656-2131, ext. 2669. Fax: (418) 656-7176. E-mail: ann.huletsky{at}rsvs.ulaval.ca.

    REFERENCES
Top
Abstract
Text
References

1. Ambler, R. P. 1980. The structure of beta -lactamases. Philos. Trans. R. Soc. London Ser. B. 289:321-331[Abstract/Free Full Text].
2. Bennett, P. M., and I. Chopra. 1993. Molecular basis of beta -lactamase induction in bacteria. Antimicrob. Agents Chemother. 37:153-158[Free Full Text].
3. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for beta -lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233[Medline].
4. Campbell, J. I. A., O. Ciofu, and N. Høiby. 1997. Pseudomonas aeruginosa isolates from patients with cystic fibrosis have different beta -lactamase expression phenotypes but are homogeneous in the ampC-ampR genetic region. Antimicrob. Agents Chemother. 41:1380-1384[Abstract].
5. Dietz, H., D. Pfeifle, and B. Wiedemann. 1997. The signal molecule for beta -lactamase induction in Enterobacter cloacae is the anhydromuramyl-pentapeptide. Antimicrob. Agents Chemother. 41:2113-2120[Abstract].
6. Ehrhardt, A. F., C. C. Sanders, J. R. Romero, and J. S. Leser. 1996. Sequencing and analysis of four new Enterobacter ampD alleles. Antimicrob. Agents Chemother. 40:1953-1956[Abstract].
7. Fleischmann, R. D., M. D. Adams, O. White, R. A. Clayton, E. F. Kirkness, et al. 1995. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269:496-512[Abstract/Free Full Text].
8. Gold, L. 1988. Posttranscriptional regulatory mechanisms in Escherichia coli. Annu. Rev. Biochem. 57:199-233[Medline].
9. Höltje, J.-V., U. Kopp, A. Ursinus, and B. Wiedemann. 1994. The negative regulator of beta -lactamase induction AmpD is a N-acetyl-anhydromuramyl-L-alanine amidase. FEMS Microbiol. Lett. 122:159-164[Medline].
10. Honoré, N., M. H. Nicolas, and S. T. Cole. 1989. Regulation of enterobacterial cephalosporinase production: the role of a membrane-bound sensory transducer. Mol. Microbiol. 3:1121-1130[Medline].
11. Jacobs, C., L. J. Huang, E. Bartowsky, S. Normark, and J. T. Park. 1994. Bacterial cell wall recycling provides cytosolic muropeptides as effectors for beta -lactamase induction. EMBO J. 13:4684-4694[Medline].
12. Jacobs, C., B. Joris, M. Jamin, K. Klarsov, J. Van Beeumen, D. Mengin-Lecreulx, J. van Heijenoort, J. T. Park, S. Normark, and J.-M. Frère. 1995. AmpD, essential for both beta -lactamase regulation and cell wall recycling, is a novel cytosolic N-acetylmuramyl-L-alanine amidase. Mol. Microbiol. 15:553-559[Medline].
13. Jacobs, C., J.-M. Frère, and S. Normark. 1997. Cytosolic intermediates for cell wall biosynthesis and degradation control inducible beta -lactam resistance in gram-negative bacteria. Cell 88:823-832[Medline].
14. Kopp, U., B. Wiedemann, S. Lindquist, and S. Normark. 1993. Sequences of wild-type and mutant ampD genes of Citrobacter freundii and Enterobacter cloacae. Antimicrob. Agents Chemother. 37:224-228[Abstract/Free Full Text].
15. Korfmann, G., and C. C. Sanders. 1989. ampG is essential for high-level expression of AmpC beta -lactamase in Enterobacter cloacae. Antimicrob. Agents Chemother. 33:1946-1951[Abstract/Free Full Text].
16. Langaee, T. Y., and A. Huletsky. 1996. Characterization of the ampD gene encoding a regulator of cephalosporinase expression in Pseudomonas aeruginosa PAO1, abstr. A-37, p. 139. In Abstracts of the 96th General Meeting of the American Society for Microbiology 1996. American Society for Microbiology, Washington, D.C.
17. Langaee, T. Y., and A. Huletsky. 1997. Identification of the ampG gene encoding a signal transducer for induction of the chromosomal AmpC beta -lactamase in Pseudomonas aeruginosa PAO1, abstr. A-3, p. 1. In Abstracts of the 97th General Meeting of the American Society for Microbiology 1997. American Society for Microbiology, Washington, D.C.
18. Langley, D., and J. R. Guest. 1977. Biochemical genetics of the alpha-keto acid dehydrogenase complexes of Escherichia coli K12: isolation and biochemical properties of deletion mutants. J. Gen. Microbiol. 99:263-276[Abstract/Free Full Text].
19. Lindquist, S., M. Galleni, F. Lindberg, and S. Normark. 1989. Signalling proteins in enterobacterial AmpC beta -lactamase regulation. Mol. Microbiol. 3:1091-1102[Medline].
20. Lisser, S., and H. Margalit. 1993. Compilation of E. coli mRNA promoter sequences. Nucleic Acids Res. 21:1507-1516[Abstract/Free Full Text].
21. Lodge, J., S. Busby, and L. Piddock. 1993. Investigation of the Pseudomonas aeruginosa ampR gene and its role at the chromosomal ampC promoter. FEMS Microbiol. Lett. 111:315-320[Medline].
22. Nakai, K., and M. Kanehisha. 1991. Expert system for predicting protein localization sites in gram-negative bacteria. Proteins 11:95-110[Medline].
23. Nicolas, M. H., N. Honore, V. Jarlier, A. Philippon, and S. T. Cole. 1987. Molecular genetic analysis of cephalosporinase production and its role in beta -lactam resistance in clinical isolates of Enterobacter cloacae. Antimicrob. Agents Chemother. 31:295-299[Abstract/Free Full Text].
24. Normark, S., E. Bartowsky, J. Erickson, C. Jacobs, F. Lindberg, S. Lindquist, K. Weston-Hafer, and M. Wikström. 1994. Mechanisms of chromosomal beta -lactamase induction in Gram-negative bacteria, p. 485-503. In J.-M. Ghuysen, and R. Hakenbeck (ed.), Bacterial cell wall. Elsevier Science B.V., Amsterdam, The Netherlands.
25. Normark, S. 1995. beta -Lactamase induction in Gram-negative bacteria is intimately linked to peptidoglycan recycling. Microb. Drug Resist. 1:111-114. [Medline]
26. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed., p. 1.21-1.101. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
27. Sanders, C. C., and W. E. Sanders, Jr. 1992. beta -Lactam resistance in gram-negative bacteria: global trends and clinical impact. Clin. Infect. Dis. 15:825-839.
28. Spratt, B. G., P. J. Hedge, S. Teheesen, A. Edelman, and J. K. Broome-Smith. 1986. Kanamycin-resistant vectors that are analogues of plasmids pUC8, pUC9, pEMBL8 and pEMBL9. Gene 41:337-342[Medline].
29. Stapleton, P., K. Shannon, and I. Phillips. 1995. DNA sequence differences of ampD mutants of Citrobacter freundii. Antimicrob. Agents Chemother. 39:2494-2498[Abstract].
30. Starnbach, M. N., S. Falkow, and L. S. Tompkins. 1989. Species-specific detection of Legionella pneumophila in water by DNA amplification and hybridization. J. Clin. Microbiol. 27:1257-1261[Abstract/Free Full Text].
31. Trépanier, S., A. Prince, and A. Huletsky. 1997. Characterization of the penA and penR genes of Burkholderia cepacia 249 which encode the chromosomal class A penicillinase and its LysR-type transcriptional regulator. Antimicrob. Agents Chemother. 41:2399-2405[Abstract].
32. West, S. E. H., and B. H. Iglewski. 1988. Codon usage in Pseudomonas aeruginosa. Nucleic Acids Res. 6:9323-9335.


Antimicrobial Agents and Chemotherapy, December 1998, p. 3296-3300, Vol. 42, No. 12
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Lister, P. D., Wolter, D. J., Hanson, N. D. (2009). Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms. Clin. Microbiol. Rev. 22: 582-610 [Abstract] [Full Text]  
  • Yang, T.-C., Huang, Y.-W., Hu, R.-M., Huang, S.-C., Lin, Y.-T. (2009). AmpDI Is Involved in Expression of the Chromosomal L1 and L2 {beta}-Lactamases of Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 53: 2902-2907 [Abstract] [Full Text]  
  • Wolter, D. J., Schmidtke, A. J., Hanson, N. D., Lister, P. D. (2007). Increased Expression of ampC in Pseudomonas aeruginosa Mutants Selected with Ciprofloxacin. Antimicrob. Agents Chemother. 51: 2997-3000 [Abstract] [Full Text]  
  • Schmidtke, A. J., Hanson, N. D. (2006). Model System To Evaluate the Effect of ampD Mutations on AmpC-Mediated {beta}-Lactam Resistance.. Antimicrob. Agents Chemother. 50: 2030-2037 [Abstract] [Full Text]  
  • Juan, C., Moya, B., Perez, J. L., Oliver, A. (2006). Stepwise Upregulation of the Pseudomonas aeruginosa Chromosomal Cephalosporinase Conferring High-Level {beta}-Lactam Resistance Involves Three AmpD Homologues.. Antimicrob. Agents Chemother. 50: 1780-1787 [Abstract] [Full Text]  
  • Juan, C., Macia, M. D., Gutierrez, O., Vidal, C., Perez, J. L., Oliver, A. (2005). Molecular Mechanisms of {beta}-Lactam Resistance Mediated by AmpC Hyperproduction in Pseudomonas aeruginosa Clinical Strains. Antimicrob. Agents Chemother. 49: 4733-4738 [Abstract] [Full Text]  
  • Bagge, N., Ciofu, O., Hentzer, M., Campbell, J. I. A., Givskov, M., Hoiby, N. (2002). Constitutive High Expression of Chromosomal {beta}-Lactamase in Pseudomonas aeruginosa Caused by a New Insertion Sequence (IS1669) Located in ampD. Antimicrob. Agents Chemother. 46: 3406-3411 [Abstract] [Full Text]  
  • Naas, T., Massuard, S., Garnier, F., Nordmann, P. (2001). AmpD Is Required for Regulation of Expression of NmcA, a Carbapenem-Hydrolyzing {beta}-Lactamase of Enterobacter cloacae. Antimicrob. Agents Chemother. 45: 2908-2915 [Abstract] [Full Text]  
  • Núñez, C., Moreno, S., Cárdenas, L., Soberón-Chávez, G., Espín, G. (2000). Inactivation of the ampDE Operon Increases Transcription of algD and Affects Morphology and Encystment of Azotobacter vinelandii. J. Bacteriol. 182: 4829-4835 [Abstract] [Full Text]  
  • Langaee, T. Y., Gagnon, L., Huletsky, A. (2000). Inactivation of the ampD Gene in Pseudomonas aeruginosa Leads to Moderate-Basal-Level and Hyperinducible AmpC beta -Lactamase Expression. Antimicrob. Agents Chemother. 44: 583-589 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Langaee, T. Y.
Right arrow Articles by Huletsky, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Langaee, T. Y.
Right arrow Articles by Huletsky, A.